EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns

Shalender Bhasin iD, Douglas Seals, Marie Migaud, Nicolas Musi, Joseph A Baur

Endocrine Reviews · 09.11.2023 · 44 (6) · 1047-1073

DOI: 10.1210/endrev/bnad019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 26.06.2023. Verfasst von Shalender Bhasin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Harvard Medical School, Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Indep…. Hauptthemen laut MEDLINE: Fatty Liver, Neurodegenerative Diseases. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 305 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent research has unveiled an expansive role of NAD+ in cellular energy generation, redox reactions, and as a substrate or cosubstrate in signaling pathways that regulate health span and aging. This review provides a critical appraisal of the clinical pharmacology and the preclinical and clinical evidence for therapeutic effects of NAD+ precursors for age-related conditions, with a particular focus on cardiometabolic disorders, and discusses gaps in current knowledge. NAD+ levels decrease throughout life; age-related decline in NAD+ bioavailability has been postulated to be a contributor to many age-related diseases. Raising NAD+ levels in model organisms by administration of NAD+ precursors improves glucose and lipid metabolism; attenuates diet-induced weight gain, diabetes, diabetic kidney disease, and hepatic steatosis; reduces endothelial dysfunction; protects heart from ischemic injury; improves left ventricular function in models of heart failure; attenuates cerebrovascular and neurodegenerative disorders; and increases health span. Early human studies show that NAD+ levels can be raised safely in blood and some tissues by oral NAD+ precursors and suggest benefit in preventing nonmelanotic skin cancer, modestly reducing blood pressure and improving lipid profile in older adults with obesity or overweight; preventing kidney injury in at-risk patients; and suppressing inflammation in Parkinson disease and SARS-CoV-2 infection. Clinical pharmacology, metabolism, and therapeutic mechanisms of NAD+ precursors remain incompletely understood. We suggest that these early findings provide the rationale for adequately powered randomized trials to evaluate the efficacy of NAD+ augmentation as a therapeutic strategy to prevent and treat metabolic disorders and age-related conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverNeurodegenerative DiseasesHumansAgedNADAgingBiology

Stichwörter der Autor:innen

NADNAD boostersNAD metabolismNAD precursorsagingclinical applications of NAD boostersgerosciencemechanisms of agingpharmacologic approaches for augmenting NADpharmacology of NAD boosters

Substanzen

NAD

Autor:innen und Institutionen

  • Department of Medicine, Harvard Medical School, Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Department of Integrative Physiology and Medicine, University of Colorado Boulder, Boulder, CO 80309, USA.
  • Department of Pharmacology, Mitchell Cancer Institute, College of Medicine, University of Southern Alabama, Mobile, AL 36688, USA.
  • Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Department of Physiology, Institute for Diabetes, Obesity & Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

ORCID-Profile: Shalender Bhasin

Förderung

  • NHLBI NIH HHS
  • NIH

Zitieren

APA

Bhasin, S., Seals, D., Migaud, M., Musi, N., & Baur, J. A. (2023). Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns. Endocrine Reviews, 44(6), 1047-1073. https://doi.org/10.1210/endrev/bnad019

Vancouver

Bhasin S, Seals D, Migaud M, Musi N, Baur JA. Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns. Endocrine Reviews. 2023;44(6):1047-1073. doi:10.1210/endrev/bnad019

BibTeX
@article{Bhasin2023,
  author = {Bhasin, Shalender and Seals, Douglas and Migaud, Marie and Musi, Nicolas and Baur, Joseph A},
  title = {Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns},
  journal = {Endocrine Reviews},
  year = {2023},
  volume = {44},
  number = {6},
  pages = {1047--1073},
  doi = {10.1210/endrev/bnad019}
}
Kostenlos starten →